3Muto T,Kamiya J,Sawada T,Konishi F,Sugihara K,Kubota Y,Adachi M,Agawa S,Saito Y,orioka Y,et al.Small ""flat adenoma"" of the large bowel with special reference to its clinicopathologic features.Dis Colon Rectum,1985,28:847～851.
4Morita T,Tomita N,Ohue M,Sekimoto M,Yamamoto H,Ohnishi T,Tada M,Ikenaga M,Miyake Y,Sakita I,Tamaki Y,Matsuura N,Ito M,Monden M.Molecular analysis of diminutive,flat,depressed colorectal lesions:are they precursors of polypoid adenoma or early stage carcin
5Saitoh Y,Waxman I,West AB,Popnikolov NK,Gatalica Z,Watari J,Obara T,Kohgo Y,Pasricha PJ.Prevalence and distinctive biologic features of flat colorectal adenomas in a North American population.Gastroenterology,2001,120:1657～1665.
6Smyrk T,Lynch HT.Colorectal cancer:Molecular and cellular abnormalities.In:Bertino JR,ed.Encyclopedia of Cancer.San Diego:Acdemic Press,1997.451-463.
7Fujii T,Rembacken BJ,Dixon MF,Yoshida S,Axon AT.Flat adenomas in the United Kingdom:are treatable cancers being missed? Endoscopy,1998,30:437-443.
8Fearon ER Vogelstein B.A genetic model for colorectal tumorigenesis.ce11,1990,61:759-767.
1Williams CS, DuBois RN.Prostaglandin endoperoxide synthase: why two isoforms? Am J Physiol,1996, 270 (3 Pt 1):G393～400.
2Giardiello FM, Offerhaus GJ, DuBois RN. The role of nonsteroidal anti-inflammatorydrugs in colorectal cancer prevention. Eur J Cancer, 1995,31A: 1071～1076.
6Sharon P, Stenson WF. Enhanced synthesis of leukotriene B4 by colonic mucosa ininflammatory bowel disease. Gastroenterology, 1984, 86:453 ～460.
7Masferrer JL, Reddy ST, Zweifel BS, Seibert K,Needleman P, Gilbert RS, HerschmanHR. In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 inperitoneal macrophages. J Pharmacol Exp Ther, 1994, 270: 1340～1344.
8Izutani R, Loh EY, Reinecker H, et al. Increased expression of interleukin-8 mRNAin ulcerative colitis and Crohn's disease mucosa and epithelial cell. Inflammatory BowelDis, 1995, 1: 37～47.
9Reuter BK, Asfaha S, Buret A, Sharkey KA,Wallace JL. Exacerbation ofinflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. JClin Invest, 1996, 98:2076～2085.
10Oshima M, Dinchuk JE, Kargman SL, Oshima H,Hancock B, Kwong E, Trzaskos JM, EvansJF,Taketo MM. Suppression of intestinal polyposis in Apc delta716 knockout mice byinhibition of cyclooxygenase 2 (COX-2). Cell, 1996, 87: 803～809.
3Japanese Research Society for cancer of the colon and rectum. General rules for clinical and pathological studies on cancer of colon, rectum and anus [M]. 6ed. Tokyo: KinbaraShuppan, 1998: 32-36.
4Schlemper RJ, Hirata I, Dixon MF. The macroscopic classification of early oeoplasia of the digestive tract [ J ]. Endoscopy, 2002, 34 (2) : 163-168.
5Diebold MD, Samalin E, Merle C, et al. Colonic fiat neoplasia: frequency and concordance between endoscopic appearance and histologi- cal diagnosis in a French prospective series [ J]. Am J Gastroenterol, 2004, 99(9) : 1795-1800.
6Saitoh Y, Waxman J, West AB, et al. Prevalence and distinctive biologic features of fiat eoloreetal adenomas in a North American population [J]. Gastroenterology, 2001, 120(7): 1657-1665.
7Hurlstone DP, Cross SS, Adam I, et al. A prospective clinicopathological and endoscopic evaluation of flat and depressed colorectal lesions in the United Kingdom [ J]. Am J Gastroenterol, 2003, 98 ( 11 ): 2543 -2549.
8Tsuda S, Veress B, Toth E, et al. Flat and depressed colorectal tumours in a southern Swedish population: a prospective chromoendo- scopic and histopathological study [ J]. Gut, 2002, 51 (10): 550-555.
9Church JM, Muto T, Appau K. Flat lesions of the colorectal mucosa: differences in recognition between Japanese and American endoscopists [J]. Dis Colon Rectum, 2004, 47(9): 1462-1466.
10Haines A, Hill MJ, Thompson MH, et al.A prospective study of faecal bile acids and colorectal cancer [ J ]. Eur J Cancer, 2000, 9 (5) : 317-323.
